Point-of-Care Diagnostics Market, by Technology (Lateral Flow, Agglutination Assays, Flow-Through, Solid Phase, and Biosensors), By Application (Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drugs of Abuse (DoA) Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing, and Others), By End User (Hospitals, Diagnostic Laboratories, Home-Care Settings, and Others), and Region - Global Industry Insights, and Forecast till 2025

  • Published On : Apr 2018 |
  • Pages : 148 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Point of Care Diagnostics Market - Insights

Point of care diagnosis involves testing of the samples at the point of care to facilitate rapid diagnosis and treatment plan. Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment. Technologies used in point-of-care diagnostics include lateral flow, agglutination assays, biosensors, and solid phase, which are all advanced and unique for specific conditions. For instance, lateral flow technology is used in pregnancy testing along with other applications. Only a small amount of sample is required for point of care and the procedure is completed in real-time, which has increased the adoption rate for these tests. Some of the commercially available point of care diagnostics include CoaguChek Pro II, Uni-Gold HIV, Accu-Chek Aviva meter, Alere I Influenza A & B, OneTouch Verio Flex, and ICON SC Strep A.

Increasing launch and approval of novel product is supporting growth of the market

High product and test volumes are driving growth of the Point of care diagnostics market. Furthermore, leading market players are focused on launching novel products to expand their product portfolio for treatment of several diseases using advanced technologies. For instance, in February 2018, Siemens Healthineers received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Blood Urea Nitrogen (BUN) and Total Carbon Dioxide (TCO2) point-of-care tests, which is intended for use in the diagnosis of renal diseases and metabolic imbalances. Furthermore, in 2017, Beckman Coulter Diagnostics received CE Mark clearance for new high-sensitivity troponin assay, which aids in diagnosing myocardial infarction for patients presenting with chest pain or other ischemic symptoms. Moreover, Alere, Inc. launched first-ever rapid diagnostic test, Malaria Ag P.f, for detection of asymptomatic malaria infection in May 2017. Furthermore, Alere, Inc. along with its partner company GenPrime, Inc., launched point of care testing device, the xReader for work-place drug testing in 2016.

The global point of care diagnostics market was valued at US$ 18,219.4 million in 2016 and is expected to witness a robust CAGR of 9.2% over the forecast period (2017 – 2025).

Figure 1. Global Point of Care Diagnostics Market Share, by Technology (%) 2017 and 2025

point of care diagnostics market

Source: Coherent Market Insights Analysis (2017)

Increasing prevalence of chronic diseases is expected to propel demand for diagnostic tests providing rapid results

Prevalence of infectious diseases such as HIV, tuberculosis (TB), and malaria is increasing in emerging economies such as Africa and Asia Pacific. For instance, according to the World Health Organization (WHO), in 2016, an estimated 36.7 million people were suffering from HIV worldwide. According to the World Health Organization (WHO), in 2015, around 3, 23,000 new cases of TB and an estimated 32,000 deaths from tuberculosis were reported in the European region. Moreover, out of around 3, 23,000 people with TB cases in this region, 27,000 people were reported to be suffering from HIV co-infection. Incidences of chronic diseases such as cancer, diabetes, and cardiovascular conditions is increasing, which is expected to positively impact growth of the point of care diagnostics market. This is due to increasing demand from patients for rapid diagnosis and treatment. For instance, according to the World Health Organization (WHO), cancer was responsible for 8.8 million deaths in 2015, worldwide. Furthermore, according to American Diabetes Association (ADA), in 2015, around 30.3 million people in the U.S. were suffering from diabetes and around 1.5 million people are diagnosed with the disease annually. POC diagnostic tests aid in quick diagnosis and treatment initiation, therefore, the market is projected to witness high growth over the forecast period.

Point of care diagnostic products are often subjected to recalls due to product issues, which may be technical or any other malfunctioning. For instance, Abbott Point of Care, Inc.’s product i-Stat PT/INR was recalled in 2015, due to result associated problems. Furthermore, Alere voluntarily recalled Class I products INRatio and INRatio2 PT/INR monitoring systems and INRatio test strips were recalled in 2016 due to possibility of generation of incorrect results by the products. These factors are expected to hinder growth of the market.

Major players operating in the point of care diagnostics market include Danaher Corporation, Abbott Laboratories, Acon Laboratories, Inc., Hoffman-La Roche Ltd., Becton, Dickinson, and Company, Johnson & Johnson, Trinity Biotech Plc., and Siemens Healthineers.

Cancer prevalence is increasing worldwide and often it is diagnosed in late stage, which affects the medical decision significantly. As cancer may be potentially cured if diagnosed in early stages, the importance of rapid point of care diagnostic tests is increasing in medical sector. Currently, cancer diagnosis is done by invasive techniques such as biopsy. Rapid biomarker identification tests are not present in extensive number. The U.S. Food & Drug Administration has approved breast cancer test in March 2018, offered by the company 23andMe. This cancer test is capable of diagnosing three of the 1000 mutations in the BRCA1 and BRCA2 genes associated with increased risk of breast, ovarian, and prostate cancer. Cancer point of care diagnostic/biomarker testing holds huge potential for market growth, as there is no significant competition in this sector.

Market Dynamics

Demand for point of care testing is increasing, owing to factors such as lack of access to centralized laboratories in emerging economies such as Asia Pacific, independence from centralized laboratories as the testing can be done on the spot without the need of laboratory facilities, and rapid diagnosis, which is expected to create significant demand for point of care diagnostics market. The market is expected to gain significant growth, owing to further developments in point-of-care diagnostics aimed towards impacting medical outcomes, increased adoption of rapid medical diagnostic devices, and rising prevalence of chronic diseases such as HIV, infectious diseases, and diabetes. Development of innovative point of care tests for wide number of applications is expected to fuel growth of the market. Product recalls in point of care diagnostics market and supply chain related issues in remote areas are expected to hinder the market growth

Key features of the study:

  • This report provides in-depth analysis of point of care diagnostics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global point of care diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key companies covered as a part of this study include Danaher Corporation, Abbott Laboratories, Acon Laboratories, Inc., Hoffman-La Roche Ltd., Becton, Dickinson, and Company, Johnson & Johnson, Trinity Biotech Plc, and Siemens Healthineers.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global point of care diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the point of care diagnostics market

Detailed Segmentation:

  • Global Point of Care Diagnostics Market, By Technology:
    • Lateral Flow
    • Agglutination Assays
    • Flow-Through
    • Solid Phase
    • Biosensors
  • Global Point of Care Diagnostics Market, By Application:
    • Cardio Metabolic Testing
    • Infectious Disease Testing
    • Nephrology Testing
    • DoA Testing
    • Blood Glucose Testing
    • Pregnancy Testing
    • Cancer Biomarker Testing
    • Others
  • Global Point of Care Diagnostics Market, By End User:
    • Hospitals
    • Diagnostic Laboratories
    • Home-Care Settings
    • Others
  • Global Point of Care Diagnostics Market, By Geography:
    • North America
      • By Technology:
        • Lateral Flow
        • Agglutination Assays
        • Flow-Through
        • Solid Phase
        • Biosensors
      • By Application:
        • Cardio Metabolic Testing
        • Infectious Disease Testing
        • Nephrology Testing
        • DoA Testing
        • Blood Glucose Testing
        • Pregnancy Testing
        • Cancer Biomarker Testing
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Home-Care Settings
        • Others
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Technology:
        • Lateral Flow
        • Agglutination Assays
        • Flow-Through
        • Solid Phase
        • Biosensors
      • By Application:
        • Cardio Metabolic Testing
        • Infectious Disease Testing
        • Nephrology Testing
        • DoA Testing
        • Blood Glucose Testing
        • Pregnancy Testing
        • Cancer Biomarker Testing
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Home-Care Settings
        • Others
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Technology:
        • Lateral Flow
        • Agglutination Assays
        • Flow-Through
        • Solid Phase
        • Biosensors
      • By Application:
        • Cardio Metabolic Testing
        • Infectious Disease Testing
        • Nephrology Testing
        • DoA Testing
        • Blood Glucose Testing
        • Pregnancy Testing
        • Cancer Biomarker Testing
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Home-Care Settings
        • Others
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Technology:
        • Lateral Flow
        • Agglutination Assays
        • Flow-Through
        • Solid Phase
        • Biosensors
      • By Application:
        • Cardio Metabolic Testing
        • Infectious Disease Testing
        • Nephrology Testing
        • DoA Testing
        • Blood Glucose Testing
        • Pregnancy Testing
        • Cancer Biomarker Testing
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Home-Care Settings
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • By Technology:
        • Lateral Flow
        • Agglutination Assays
        • Flow-Through
        • Solid Phase
        • Biosensors
      • By Application:
        • Cardio Metabolic Testing
        • Infectious Disease Testing
        • Nephrology Testing
        • DoA Testing
        • Blood Glucose Testing
        • Pregnancy Testing
        • Cancer Biomarker Testing
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Home-Care Settings
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Technology:
        • Lateral Flow
        • Agglutination Assays
        • Flow-Through
        • Solid Phase
        • Biosensors
      • By Application:
        • Cardio Metabolic Testing
        • Infectious Disease Testing
        • Nephrology Testing
        • DoA Testing
        • Blood Glucose Testing
        • Pregnancy Testing
        • Cancer Biomarker Testing
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Home-Care Settings
        • Others
      • By Country:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Danaher Corporation*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Abbott Laboratories
    • Acon Laboratories, Inc.
    • Hoffman-La Roche Ltd.
    • Becton, Dickinson, and Company
    • Johnson & Johnson
    • Trinity Biotech Plc
    • Siemens Healthineers

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • PEST Analysis
  4. Global Point of Care Diagnostics Market, By Technology, 2015 – 2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016 – 2025
      • Segment Trends
    • Lateral Flow
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Agglutination Assays
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Flow-Through
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Solid Phase
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Biosensors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
  5. Global Point of Care Diagnostics Market, By Application, 2015 – 2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016 – 2025
      • Segment Trends
    • Cardio Metabolic Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Infectious Disease Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Nephrology Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Drugs of Abuse (DoA) Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Blood Glucose Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Pregnancy Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Cancer Biomarker Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
  6. Global Point of Care Diagnostics Market, By End User, 2015 – 2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016 – 2025
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Home-Care Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Diagnostic Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Mn)
  7. Global Point of Care Diagnostics Market, By Regions, 2015 – 2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2016 – 2025
    • North America
      • Market Size and Forecast, By Technology, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 – 2025 (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Technology, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 – 2025 (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Technology, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 – 2025 (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of APAC
    • Latin America
      • Market Size and Forecast, By Technology, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 – 2025 (US$ Mn)
        • Brazil
        • Mexico
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Technology, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 – 2025 (US$ Mn)
        • Central Africa
        • South Africa
        • North Africa
    • Middle East
      • Market Size and Forecast, By Technology, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015 – 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 – 2025 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Danaher Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Acon Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Hoffman-La Roche Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Becton, Dickinson, and Company
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Trinity Biotech Plc
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Siemens Healthineers
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 40 market data tables and 44 figures on "Point of Care Diagnostics Market - Global forecast to 2025”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.